Holen Sie sich die Stockscreener-App
11.19
8.06%
-0.985
Schlusskurs vom Vortag:
$12.17
Offen:
$11.98
24-Stunden-Volumen:
585.96K
Relative Volume:
0.40
Marktkapitalisierung:
$301.90M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-49.81M
KGV:
-5.1878
EPS:
-2.156
Netto-Cashflow:
$-42.93M
1W Leistung:
-17.85%
1M Leistung:
+62.39%
6M Leistung:
+358.57%
1J Leistung:
+201.59%
1-Tages-Spanne:
$10.20
$11.98
1-Wochen-Bereich:
$10.20
$15.18
52-Wochen-Spanne:
$1.60
$15.18
Alto Neuroscience Inc Stock (ANRO) Company Profile
Firmenname
Alto Neuroscience Inc
Sektor
Branche
Telefon
773-255-5012
Adresse
650 CASTRO STREET, SUITE 450, MOUNTAIN VIEW
Vergleichen Sie ANRO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ANRO
Alto Neuroscience Inc
|
11.15 | 376.16M | 0 | -49.81M | -42.93M | -2.156 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.10 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
629.34 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.65 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
836.79 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.68 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Alto Neuroscience Inc Stock (ANRO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-29 | Eingeleitet | Chardan Capital Markets | Buy |
| 2024-10-23 | Herabstufung | Rodman & Renshaw | Buy → Neutral |
| 2024-10-23 | Herabstufung | Wedbush | Outperform → Neutral |
| 2024-09-03 | Eingeleitet | Wedbush | Outperform |
| 2024-02-27 | Eingeleitet | Jefferies | Buy |
| 2024-02-27 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-02-27 | Eingeleitet | Stifel | Buy |
| 2024-02-27 | Eingeleitet | TD Cowen | Outperform |
| 2024-02-27 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Alto Neuroscience Inc Aktie (ANRO) Neueste Nachrichten
Can Alto Neuroscience Inc. stock outperform in 2025 bull marketFed Meeting & Real-Time Sentiment Analysis - newser.com
How risky is Alto Neuroscience Inc. stock nowInflation Watch & Real-Time Buy Signal Alerts - newser.com
Will Alto Neuroscience Inc. stock recover faster than marketJuly 2025 Selloffs & High Yield Equity Trading Tips - newser.com
Will Alto Neuroscience Inc. stock go up soonQuarterly Portfolio Report & Long-Term Investment Growth Plans - newser.com
How to read the order book for Alto Neuroscience Inc.2025 Key Highlights & Capital Protection Trading Alerts - newser.com
Can Alto Neuroscience Inc. stock test all time highs2025 Breakouts & Breakdowns & Weekly Market Pulse Updates - newser.com
Why retail investors pile into Alto Neuroscience Inc. stockJuly 2025 Volume & Free Technical Confirmation Trade Alerts - newser.com
Is Alto Neuroscience Inc. stock gaining market shareGap Down & Entry and Exit Point Strategies - newser.com
Quantitative breakdown of Alto Neuroscience Inc. recent moveWall Street Watch & Free Daily Entry Point Trade Alerts - newser.com
Key resistance and support levels for Alto Neuroscience Inc.2025 Dividend Review & Free Real-Time Market Sentiment Alerts - newser.com
Price action breakdown for Alto Neuroscience Inc.July 2025 Analyst Calls & Free Fast Gain Swing Trade Alerts - newser.com
Full technical analysis of Alto Neuroscience Inc. stockRisk Management & Risk Managed Trade Strategies - newser.com
Relative strength of Alto Neuroscience Inc. in sector analysis2025 Investor Takeaways & Long-Term Safe Investment Plans - newser.com
What earnings revisions data tells us about Alto Neuroscience Inc.Portfolio Return Summary & High Conviction Investment Ideas - newser.com
Risk adjusted return profile for Alto Neuroscience Inc. analyzedTrade Exit Report & Technical Entry and Exit Alerts - newser.com
What the charts say about Alto Neuroscience Inc. todayEarnings Beat & Free Community Consensus Stock Picks - newser.com
Can Alto Neuroscience Inc. hit a new high this monthQuarterly Profit Report & AI Powered Market Entry Ideas - newser.com
What indicators show strength in Alto Neuroscience Inc.July 2025 Analyst Calls & Weekly Chart Analysis and Trade Guides - newser.com
Chart based exit strategy for Alto Neuroscience Inc.Long Setup & Consistent Income Trade Ideas - newser.com
Why Alto Neuroscience Inc. stock gets analyst attentionJuly 2025 Earnings & Expert Verified Movement Alerts - newser.com
Is Alto Neuroscience Inc. stock a buy during volatile marketsTrade Ideas & AI Optimized Trading Strategy Guides - newser.com
When is the best time to exit Alto Neuroscience Inc.Dollar Strength & Short-Term Trading Alerts - newser.com
How to track smart money flows in Alto Neuroscience Inc.July 2025 Gainers & Safe Entry Trade Signal Reports - newser.com
Alto Neuroscience, Inc. (NYSE:ANRO) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
What data driven models say about Alto Neuroscience Inc.’s futureMarket Risk Summary & Daily Profit Focused Screening - newser.com
Can Alto Neuroscience Inc. stock sustain free cash flow growth2025 Performance Recap & Free Technical Confirmation Trade Alerts - newser.com
What makes Alto Neuroscience Inc. stock attractive to growth funds2025 Major Catalysts & Technical Entry and Exit Tips - newser.com
COMMODORE CAPITAL LP Acquires Significant Stake in Alto Neuroscience Inc - GuruFocus
Will Alto Neuroscience Inc. stock maintain growth storyMarket Performance Report & Daily Market Momentum Tracking - newser.com
Is Alto Neuroscience Inc. trending in predictive chart modelsWatch List & Daily Stock Trend Watchlist - newser.com
What institutional flow reveals about Alto Neuroscience Inc.Weekly Trade Report & Safe Capital Growth Plans - newser.com
Finanzdaten der Alto Neuroscience Inc-Aktie (ANRO)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.19%
0.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):